CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
1.4859
0.68%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0282
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-4.63)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.40)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.4759
Open 1.5059
1-Year Change 37.29%
Day's Range 1.4859 - 1.5159
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 1.4759 0.0000 0.00% 1.4759 1.4959 1.4659
Dec 16, 2024 1.4859 0.0100 0.68% 1.4759 1.4959 1.4059
Dec 13, 2024 1.4559 -0.0100 -0.68% 1.4659 1.4759 1.4059
Dec 12, 2024 1.4559 0.0700 5.05% 1.3859 1.4759 1.3659
Dec 11, 2024 1.4059 -0.0300 -2.09% 1.4359 1.4859 1.3959
Dec 10, 2024 1.4659 0.0100 0.69% 1.4559 1.5459 1.4559
Dec 9, 2024 1.4859 -0.0100 -0.67% 1.4959 1.4959 1.4359
Dec 6, 2024 1.4759 0.0500 3.51% 1.4259 1.5159 1.4259
Dec 5, 2024 1.4259 0.0500 3.63% 1.3759 1.4459 1.3759
Dec 4, 2024 1.3559 0.0000 0.00% 1.3559 1.3759 1.3359
Dec 3, 2024 1.3659 -0.0500 -3.53% 1.4159 1.4159 1.3459
Dec 2, 2024 1.3859 0.0900 6.94% 1.2959 1.4159 1.2959
Nov 29, 2024 1.3459 -0.0100 -0.74% 1.3559 1.3559 1.3259
Nov 27, 2024 1.3659 0.0400 3.02% 1.3259 1.3859 1.3259
Nov 26, 2024 1.3659 0.0600 4.59% 1.3059 1.4159 1.3059
Nov 25, 2024 1.3459 0.0100 0.75% 1.3359 1.4359 1.3059
Nov 22, 2024 1.3259 0.1000 8.16% 1.2259 1.3559 1.2059
Nov 21, 2024 1.2759 -0.0200 -1.54% 1.2959 1.3159 1.2459
Nov 20, 2024 1.2959 -0.0400 -2.99% 1.3359 1.3459 1.2759
Nov 19, 2024 1.3459 0.0500 3.86% 1.2959 1.3559 1.2359

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

NanoViricides, Inc. Company profile

About NanoViricides Inc

NanoViricides, Inc. is a nano-biopharmaceutical company. The Company is engaged in discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company's nanoviricide technology enables direct attacks at multiple points on a virus particle. The nanomedicines technology also enables attacking the rapid intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company is developing antiviral drug candidate, NV-CoV-2 drug for the treatment of COVID-19 infected sick persons. Its other clinical drug candidate NV-HHV-101 a skin cream for the treatment of shingles rash.

Financial summary

BRIEF: For the six months ended 31 December 2021, NanoViricides Inc revenues was not reported. Net loss decreased 2% to $4.5M. Lower net loss reflects General and administrative decrease of 21% to $1.2M (expense), Interest expense decrease of 96% to $4K (expense), Loss on disposal of property and equip. decrease from $2K (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.44 to -$0.39.

Equity composition

Common Stock $.001 Par, 2/11, 300M auth., 139,906,601 issd. Insider owns 30.00%. Conv. Pref. Stock Class A $.001 Par, 10M auth., 7,593,750 issd. 09/13, 1-for-3.5 Reverse Stock split.

Industry: Bio Therapeutic Drugs

1 Controls Drive
SHELTON
CONNECTICUT 06484
US

People also watch

ETH/USD

3,869.41 Price
-1.670% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

BTC/USD

104,210.30 Price
-2.280% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,636.12 Price
-0.410% 1D Chg, %
Long position overnight fee -0.0083%
Short position overnight fee 0.0001%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,988.50 Price
+0.050% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading